473PASTRIS global real world study of osimertinib in patients (pts) with EGFR T790M non-small cell lung cancer (NSCLC): Subpopulation analyses. (25th November 2018) - Provencio, M; Cheema, P K; Vansteenkiste, J F; Cho, B C; Zhou, C; Yu, J; Martin, C; Park, K; He, Y; Hu, Y; Vicente, D; Miranda, M; et al.